tiprankstipranks
pc:seedt

SEED Therapeutics Inc

SEED Therapeutics Inc is a clinical-stage biotechnology company specializing in the development of rationally designed molecular glue degraders to target diseases driven by traditionally undruggable proteins. Utilizing its proprietary RITE3™ platform, SEED Therapeutics integrates structure-based drug design, computational chemistry, and chemical biology to innovate targeted protein degradation solutions. The company's pipeline includes nine programs across various therapeutic areas such as oncology, neurodegeneration, immunology, and virology, with its lead candidate, ST-01156, entering clinical development for Ewing sarcoma and other RBM39-dependent cancers.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$30M
Total Amount Raised$30M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$30M
Latest Funding Amount$30M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 23, 2025
Series A
$30.00M

Investors

Investor Name
Funding Round
Series A
Series A

Related News and Analysis